05/26/2021
Nuventra is excited to announce that we have joined CATO SMS. Together, Nuventra and CATO SMS will offer a portfolio of solutions encompassing regulatory consulting, full-service clinical trial operations, expert biostatistical consulting and clinical pharmacology services. Nuventra’s Geoffrey Banks, Ph.D. and Alex Shaw, Ph.D. will continue to spearhead operations in the new clinical pharmacology business being created at CATO SMS.
Nuventra is excited to announce that we have joined CATO SMS, a global provider of specialized clinical research solutions. As a leader in clinical pharmacology sciences & services, together with CATO SMS we can build an even stronger offering for our clients.